Beijing Hotgen Biotech Co., Ltd.
Location
Beijing
Founded
2005-10-23
Website
Risk Signals
7 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., In Vitro and In Vivo Diagnostic Substances), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Beijing Hotgen Biotech Co., Ltd.
Live alerts from global media, monitored by Business Radar
2025-03-22 (yicaiglobal.com)
Net profit plummeted but the stock price rose sharply, and Tongcheng Hotjing, a shareholder of Hotgen Biotech, planned to reduce its holdings of no more than 2% of its shares
On the evening of March 21, Hotgen Biotechnology (688068) announced that the company recently received the "Notification Letter on Reducing the Company's Shares" issued by shareholder Tongcheng Hotjing. Due to its own capital needs, shareholder Tongcheng Hotjing plans to reduce its holdings of the company's shares by centralized bidding and block trading to no more than 1.8 million shares, accounting for 1.9465% of the company's total share capital.
Read more